SDEV — Stablecoin Development Share News
0.000.00%
Last trade - 00:00Brief: Tether Says Participated In A $134 Million Financing Round For Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Announces Name Change To Stablecoin Development Corporation
Brief: Novabay Pharmaceuticals Says David Lazar Resigns As CEO
Brief: NovaBay Pharmaceuticals Files For Mixed Shelf Of Up To $200 Million - SEC Filing
Brief: NovaBay Pharmaceuticals Announces One-Time Special Cash Dividend Of $0.80 Per Share
NovaBay jumps after $6 million investment, new CEO
Brief: NovaBay Pharmaceuticals Enters Into $6 Million Securities Purchase Agreement With Investor David Lazar
Brief: Novabay Pharmaceuticals Engages Financial Advisor Should Stockholders Fail To Approve Dissolution Proposal
Brief: Novabay Pharmaceuticals Completes The Sale Of Its Eyecare Business To Prn
Brief: NovaBay Pharmaceuticals ISS Supports Co's Proposals To Authorize Sale Of Its Avenova Brand
Brief: Novabay Pharmaceuticals accepts revised offer from Nutriceuticals
Brief: NovaBay Pharmaceuticals Board Determines Unsolicited Offer Is Superior To Asset Purchase Agreement With PRN Physician Recommended Nutriceuticals, LLC
NovaBay rises on deal to sell assets of eye care brand Avenova
Brief: Acumen Health Holdings To Acquire The Avenova Brand From Novabay Pharmaceuticals
Brief: Novabay Pharmaceuticals Signs Definitive Agreement To Sell Its Avenova Assets
Brief: NovaBay Pharmaceuticals Announces Closing Of $3.87 Mln Underwritten Public Offering
Brief: NovaBay Pharmaceuticals Announces Pricing Of $3.5 Mln Underwritten Public Offering
Brief: NovaBay Pharmaceuticals Offers 20% Discounts On Avenova Eyecare Products During Amazon Prime Day
Brief: NovaBay Pharmaceuticals' Plan Of Compliance Accepted By The NYSE American